Yan et al. showed that HBV-related HCC patients had varying levels of PD-1+ CD8+ cells and inducible T-cell COStimulator (ICOS)+ Tregs at different HCC stages. The gene discussed is PDCD1; the disease is hepatocellular carcinoma.